SASAKI SATOSHI
No ORCID on file
· 42 papers in corpus
· active 1997-2009
Frequent coauthors
- CHOH NOBUO 24
- FURUYA SHUICHI 24
- BABA ATSUO 18
- HARADA MASATAKA 18
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2009
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2008
The present invention provides a compound which has metastin receptor antagonist activity and is useful for preventing and treating hormone-dependent cancer, benign prostatomegaly, endometriosis, precocious puberty, uterine myoma or the lik…
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
2007
Discloses is a compound which has a metastin receptor antagonistic activityand is useful for the prevention/treatment of hormone-dependent cancer, benignprostatomegaly, endometriosis, precocious puberty, hysteromyoma or the like.A compound …
1998
The present quinoline derivatives and compositions having gonadotropin-releasing hormone antagonistic activity are useful as propylactics or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for exampl…
1998
The present quinoline derivatives and compositions having gonadotropin-releasing hormone antagonistic activity are useful as propylactics or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for exampl…
1998
The present quinoline derivatives and compositions having gonadotropin-releasing hormone antagonistic activity are useful as propylactics or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for exampl…
1998
The present quinoline derivatives and compositions having gonadotropin-releasing hormone antagonistic activity are useful as propylactics or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for exampl…
1998
The present quinoline derivatives and compositions having gonadotropin-releasing hormone antagonistic activity are useful as propylactics or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for exampl…
1998
The present quinoline derivatives and compositions having gonadotropin-releasing hormone antagonistic activity are useful as propylactics or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for exampl…
1998
The present thienopyrimidine derivatives and compositions having gonadotropin-releasing hormone antagonistic activity are useful as propylactics or therapeutic agents for the prevention or treatment of several hormone dependent diseases, fo…